Lumida
/GLSI
⌘K
Greenwich Lifesciences Inc

Greenwich Lifesciences Inc

GLSI
$15.45USD↑+2.59%+0.39 today

MARKET CAP

226.8M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$15 – $16

52W RANGE

$8
$34

AI Summary

Stalk
TrimMedium

GLSI remains entrenched in a Stage 4 decline following a decisive Support Failure. Price is extended into extreme oversold conditions but has only staged a bounce up to yet-unretested overhead EMAs. The medium-term bias is bearish, and preferred execution is deferred sell-side engagement on rallies into the declining 9/21 EMAs and 50 DMA rather than chasing current weakness.

  • ↑MACD flipped positive on Aug 3, leading to gains 90% of past cases.
  • ↑High momentum factors support continued price strength.
  • ↓Anticipated -$0.33 EPS in Aug 2026 points to shrinking earnings.
Full analysis →

Buying

2

institutions

Selling

1

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY485.85 K11.40 M+51.99 K+9.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY2.91 K67.56 K+302.00+20.7%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-17.40 K-100.0%0.00%